MarketPeel
Insider Trading Intelligence
TD

Tara Desilva

COEP
DIRECTOR · COEPTIS THERAPEUTICS HOLDINGS, INC. · CIK 0001952535
FILING MIX · LIFETIME100%/0%
BUYS
6
SELLS
0
TOTAL VALUE
$61.5K
COMPANIES
1
ACTIVE SINCE
Jan 2023
HOLDINGS NOW
8,950
AVG SELL PX
TRADE KIND
SHOWING 6 / 6
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Tara Desilva, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+0.00%-9.84%+1.21%-11.04%-11.04%
14d2+0.00%-7.38%+2.25%-9.63%-9.63%
30d2+0.00%-26.21%+5.10%-31.31%-31.31%
60d2+0.00%-30.33%+8.41%-38.74%-38.74%
90d2+0.00%-29.51%+9.01%-38.51%-38.51%
180d2+0.00%-53.77%+18.50%-72.27%-72.27%
1y2+0.00%-37.95%+23.34%-61.29%-61.29%
2y2+100.00%+13.69%+48.15%-34.46%-34.46%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
COEP · 8,950 shares · as of Feb 11, 2026
08,06716,13324,20032,266202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 6 buys / 0 sellsCOVERAGE · 13 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
COEP
COEPTIS THERAPEUTICS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
3,2508,950Feb 11, 2026Feb 13, 2026View →
COEP
COEPTIS THERAPEUTICS HOLDINGS, INC.
PURCHASE
5,700$10.56$60.2K8,950Feb 11, 2026Feb 13, 2026View →
COEP
COEPTIS THERAPEUTICS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
5,7008,950Mar 4, 2025Mar 6, 2025View →
COEP
COEPTIS THERAPEUTICS HOLDINGS, INC.
PURCHASE
1,800$0.58$1.0K32,266Jan 12, 2024Jan 16, 2024View →
COEP
COEPTIS THERAPEUTICS HOLDINGS, INC.
PURCHASE
466$0.56$26130,466Jan 12, 2024Jan 16, 2024View →
COEP
COEPTIS THERAPEUTICS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
30,00030,000Jan 27, 2023Jan 31, 2023View →
Other insiders · COEP
Loading peer insiders…
About this filer
CIK 0001952535
ROLE
Director
PRIMARY
COEP
COMPANIES
1
ACTIVE SINCE
Jan 2023
MARKETPEEL · /INSIDER/0001952535DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback